New for 2022, the Biosimilar Medicine and Biologic Products Summit will take place from 14-16 June this year. Join leading in-house counsel and legal practitioners from across the globe to identify and seek optimal strategies to overcome critical legal and regulatory questions.
- Several blockbuster biologic drugs are scheduled to loose their patent protection before 2025 – this creates an unique business opportunity the entrance of biosimilar products and other new therapies across the European marketplace.
- “Putting the theories into practice” this is an exclusive event to overcome legal, IP and commercial challenges for a pharmaceutical, biotech company developing the next generation of biologic products
- Stay ahead of the competition by discovering the IP, Market Access and Safe Harbour strategies for Cell & Gene Therapies
- Enhance the quality of the exchange by meeting your peers face to face, and enlarge your network which you cannot do in a virtual setting.
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
Super Early Bird rate is valid until April 22!
For more information, please visit: https://www.kisacoresearch.com/events/global-biologics-cell-and-gene-legal-summit